These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2896359)
1. Zuclopenthixol and melperon in the treatment of elderly patients: a double-blind, controlled, multi-centre study. Nygaard H; Bakke K; Brudvik E; Lien GK; Moe TJ; Elgen K Pharmatherapeutica; 1988; 5(3):152-8. PubMed ID: 2896359 [TBL] [Abstract][Full Text] [Related]
2. Zuclopenthixol and haloperidol/levomepromazine in the treatment of elderly patients with symptoms of aggressiveness and agitation: a double-blind, multi-centre study. Fuglum E; Schillinger A; Andersen JB; Belstad BE; Jensen D; Müller F; Müller KJ; Schulstad B; Elgen K Pharmatherapeutica; 1989; 5(5):285-91. PubMed ID: 2568639 [TBL] [Abstract][Full Text] [Related]
3. Zuclopenthixol, melperone and haloperidol/levomepromazine in the elderly. Meta-analysis of two double-blind trials at 15 nursing homes in Norway. Nygaard HA; Fuglum E; Elgen K Curr Med Res Opin; 1992; 12(10):615-22. PubMed ID: 1353014 [TBL] [Abstract][Full Text] [Related]
4. Zuclopenthixol decanoate in the management of behavioural disorders in mentally handicapped patients. Izmeth MG; Khan SY; Kumarajeewa DI; Shivanathan S; Veall RM; Wiley YV Pharmatherapeutica; 1988; 5(4):217-27. PubMed ID: 2902642 [TBL] [Abstract][Full Text] [Related]
5. Dosing of neuroleptics in elderly demented patients with aggressive and agitated behaviour: a double-blind study with zuclopenthixol. Nygaard HA; Bakke K; Brudvik E; Elgen K; Lien GK Curr Med Res Opin; 1994; 13(4):222-32. PubMed ID: 7882702 [TBL] [Abstract][Full Text] [Related]
6. [Cisordinol and Buronil in the elderly. A controlled multi-center double-blind comparison]. Nygaard HA; Bakke K; Brudvik E; Lien GK; Moe TJ; Elgen K Tidsskr Nor Laegeforen; 1987 Mar; 107(9):827-9. PubMed ID: 3296303 [No Abstract] [Full Text] [Related]
7. A clinical assessment of zuclopenthixol dihydrochloride (Clopixol tablets) in the treatment of psychotic illness. Mann BS; Moslehuddin KS; Owen RT; Clayton AR; Rohatgi KK; Sud P; Vaddadi KS Pharmatherapeutica; 1985; 4(6):387-92. PubMed ID: 2867559 [TBL] [Abstract][Full Text] [Related]
8. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients. Walker CA Pharmatherapeutica; 1983; 3(5):289-93. PubMed ID: 6133287 [TBL] [Abstract][Full Text] [Related]
9. A 5-year follow-up study of chronic schizophrenics treated with clopenthixol decanoate. Carney MW Pharmatherapeutica; 1984; 4(1):57-63. PubMed ID: 6150493 [TBL] [Abstract][Full Text] [Related]
10. Long-term treatment of chronic schizophrenics with clopenthixol decanoate. Borsetti G; Rocco P; Spilimbergo PG; Giavedoni A; Frangiamone L; Beccaceci A; Judice A; Cisternino M; Volterra V Pharmatherapeutica; 1984; 4(1):53-6. PubMed ID: 6150492 [TBL] [Abstract][Full Text] [Related]
11. Zuclopenthixol and perphenazine in patients with acute psychotic states. A double-blind multicentre study. Remvig J; Larsen H; Rask P; Skausig OB; Skov S; Strömgren LS Pharmacopsychiatry; 1987 Jul; 20(4):147-54. PubMed ID: 3615572 [TBL] [Abstract][Full Text] [Related]
12. Zuclopenthixol acetate in a demented elderly patient with agitation. Myronuk L; Geizer M; Ancill RJ Can J Psychiatry; 1997 Apr; 42(3):325. PubMed ID: 9114954 [No Abstract] [Full Text] [Related]
13. An open clinical trial with the long-acting neuroleptic zuclopenthixol decanoate in the maintenance treatment of schizophrenia. Kazi HA Pharmatherapeutica; 1986; 4(9):555-60. PubMed ID: 3763650 [TBL] [Abstract][Full Text] [Related]
14. Zuclopenthixol acetate in Viscoleo--a new drug formulation. An open Nordic multicentre study of zuclopenthixol acetate in Viscoleo in patients with acute psychoses including mania and exacerbation of chronic psychoses. Amdisen A; Nielsen MS; Dencker SJ; Fensbo C; Ahlfors UG; Gravem A; Baastrup PC; Bjerkenstedt L; Gunby B; Wiesel FA Acta Psychiatr Scand; 1987 Jan; 75(1):99-107. PubMed ID: 2883816 [TBL] [Abstract][Full Text] [Related]
15. Zuclopenthixol and haloperidol in patients with acute psychotic states. A double-blind, multi-centre study. Heikkilä L; Eliander H; Vartiainen H; Turunen M; Pedersen V Curr Med Res Opin; 1992; 12(9):594-603. PubMed ID: 1582239 [TBL] [Abstract][Full Text] [Related]
16. Zuclopenthixol acetate (5% in 'Viscoleo'): single-dose treatment for acutely disturbed psychotic patients. Chakravarti SK; Muthu A; Muthu PK; Naik P; Pinto RT Curr Med Res Opin; 1990; 12(1):58-65. PubMed ID: 1971560 [TBL] [Abstract][Full Text] [Related]
17. A double blind comparison of zuclopenthixol acetate with haloperidol in the management of acutely disturbed schizophrenics. Chin CN; Hamid AR; Philip G; Ramlee T; Mahmud M; Zulkifli G; Loh CC; Zakariah MS; Norhamidah MS; Suraya Y; Roslan KA; Chandramohan P; Cheah YC; Leonard AO Med J Malaysia; 1998 Dec; 53(4):365-71. PubMed ID: 10971979 [TBL] [Abstract][Full Text] [Related]
18. A double-blind placebo-controlled discontinuation study of zuclopenthixol for the treatment of aggressive disruptive behaviours in adults with mental retardation - secondary parameter analyses. Hässler F; Glaser T; Pap AF; Beneke M; Diefenbacher A; Reis O; Pharmacopsychiatry; 2008 Nov; 41(6):232-9. PubMed ID: 19067260 [TBL] [Abstract][Full Text] [Related]
19. Treatment of aggressive behavior problems in boys with intellectual disabilities using zuclopenthixol. Hässler F; Dück A; Jung M; Reis O J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):579-81. PubMed ID: 25514543 [TBL] [Abstract][Full Text] [Related]
20. A double-blind clinical investigation of cis(Z)-clopenthixol and clopenthixol in chronic schizophrenic patients. Heikkilä L; Karsten D; Valli K Acta Psychiatr Scand Suppl; 1981; 294():25-9. PubMed ID: 7041516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]